PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
28-Nov-2019 AMF Concludes its Review of the Refinancing Transactions Completed by Liminal BioSciences in April 2019 Liminal BioSciences Inc.
28-Nov-2019 A new anti-tumour treatment is one step closer to the clinic thanks to a new collaboration between In3Bio and 3P Biopharmaceuticals 3PBiopharmaceuticals
28-Nov-2019 Registration Opens for SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference SMi Group
28-Nov-2019 Orexo acquires exclusive US rights to commercialize vorvida®, a digital therapy for alcohol use disorder with scientifically proven efficacy Orexo AB
28-Nov-2019 Jubilant Biosys Commences Major Capacity Expansions for its Drug Discovery Services Business Jubilant Biosys Limited
28-Nov-2019 One Nucleus announces finalists of the BioNewsRound Award One Nucleus
28-Nov-2019 Tyvyt (Sintilimab Injection), an Innovative PD-1 Inhibitor Jointly Developed by Innovent and Lilly, is Included in the New Catalogue of National Reimbursement Drug List (NRDL) Innovent Biologics, Inc.
27-Nov-2019 FDA orders Puerto Rico fertility clinic to cease manufacturing immediately for significant violations that pose a danger to health U.S. Food and Drug Administration
27-Nov-2019 Celltrion Healthcare receives EU marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima SCTM, for the treatment of people with rheumatoid arthritis Celltrion Healthcare
27-Nov-2019 Novo Seeds expands company formation activities at BiOrigin with seasoned entrepreneurs Novo Holdings
27-Nov-2019 VFMCRP and ChemoCentryx announce positive topline data from pivotal phase-III ADVOCATE trial demonstrating avacopan’s superiority over standard of care in ANCA associated vasculitis Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
27-Nov-2019 UK life sciences company, SkinBioTherapeutics, announces end of year results following news of first commercial deal SkinBioTherapeutics plc
27-Nov-2019 Boehringer Ingelheim chooses NiceLabel solution to help support standardised labelling worldwide Boehringer Ingelheim
27-Nov-2019 How electronic trial master files are streamlining the clinical trial process MHRA
27-Nov-2019 Investment in UK cell and gene therapy manufacturing set to continue The Cell and Gene Therapy Catapult
27-Nov-2019 Accelerated demand for specialist skills in the UK cell and gene therapy industry CGT Catapult
27-Nov-2019 Hikma completes its FDA response for generic Advair® Hikma
27-Nov-2019 Return of XonveaTM Licensing Rights ALLIANCE PHARMA PLC
27-Nov-2019 Sale of 3D4Medical Limited Malin Corporation plc
27-Nov-2019 Hikma completes its FDA response in respect of generic Advair® (VR315US) Vectura Group plc